Moreover, Pei et al. showed that small molecule inhibitors of the PI3K/mTOR pathway inhibited tumor cell growth in vitro and extended survival of tumor-bearing mice, identifying this signaling pathway as a potential therapeutic target for this MB subgroup. The gene discussed is MTOR; the disease is neoplasm.